Delivery Order SPE2DB22D2007-SPE2DB25FJ5JU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $28,410.76 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed price delivery order, with an ultimate completion date of August 21, 2025, was awarded on August 20, 2025, with no set-aside designation. The contract represents a competitive award under AmerisourceBergen's larger federal contracting relationship with DLA and reflects...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,237.44 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector supply on September 9, 2025, with completion targeted for September 10, 2025. This non-set-aside, firm fixed-price delivery order represents a small-value pharmaceutical procurement fulfilled through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $21,929.06 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 MG/ML Autoinjector, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order transaction. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $23,115.58 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack), a pharmaceutical product used in the treatment of autoimmune conditions. This competitively awarded, firm fixed-price delivery order was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,302.89 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL AutoInjector on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ is a biologic medication used to treat inflammatory conditions, and this...
- The Defense Logistics Agency awarded a delivery order valued at $1,660.30 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a $6,641.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, a pharmaceutical product used in the treatment of autoimmune conditions. The contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,228.37 on August 11, 2025, for the supply of TALTZ 80 MG/ML AutoInjector (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside provisions and represents a routine pharmaceutical procurement through established federal...
- The Defense Logistics Agency awarded a $10,997 firm fixed price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, with an ultimate completion date of September 26, 2025. This delivery order, issued on September 25, 2025, represents a non-set-aside competitive award and is classified as a child contract under AmerisourceBergen's larger contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $15,780.47 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical supplies. This firm fixed price contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5JUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,905.14 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, a pharmaceutical product used in the treatment of inflammatory conditions. This firm fixed-price delivery order, awarded September 26, 2025, represents a non-competitive, non-set-aside procurement with a completion deadline of September 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's continued receipt of delivery orders under this vehicle demonstrates its capability as a critical pharmaceutical vendor serving federal medical procurement needs, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 9/26/25 |